Rahul D. Ballal's Net Worth
$1.72 Million
Who is Rahul D. Ballal?
Rahul D. Ballal has an estimated net worth of $1.72 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., and AGIOS PHARMACEUTICALS, INC..
SEC CIK
Rahul D. Ballal's CIK is 0001805097
Past Insider Trading and Trends
2022 was Rahul D. Ballal's most active year for acquiring shares with 4 total transactions. Rahul D. Ballal's most active month to acquire stocks was the month of December. 2020 was Rahul D. Ballal's most active year for disposing of shares, totalling 4 transactions. Rahul D. Ballal's most active month to dispose stocks was the month of November. 2020 saw Rahul D. Ballal paying a total of $15,750.00 for 5,000 shares, this is the most they've acquired in one year. In 2023 Rahul D. Ballal cashed out on 46,476 shares for a total of $197,366.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.51
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$18.22 | -$688,185.87 | 22.34K |
Scheduled
|
Apr 10 - Apr 11
| ||
Form 4
|
—
|
0
|
$15.88 | -$22,818.39 | 22.34K |
Scheduled
|
Apr 4
| ||
Form 4
|
—
|
0
|
$12.41 | -$43,224.64 | 22.34K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$12.34 | -$181,167.69 | 22.34K |
Scheduled
|
Mar 20
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| -27.23% | -32.86K |
$4.66 | -$153,132.26 | 87.83K |
Feb 22
| |||
Form 4
| -8.57% | -11.31K |
$3.91 | -$44,233.83 | 120.7K |
Jan 30
| |||
Form 4
| +2,342.66% | 131.4K |
—
|
—
| 137.01K |
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
$14.08 | -$109,228.15 |
0
|
Scheduled
|
Dec 17
| ||
Form 4
|
—
|
0
|
$14.08 | -$21.85 |
0
|
Scheduled
|
Dec 14
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $23.788
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +147.18% | 3.39K |
—
|
—
| 5.69K |
Jun 13
| |||
Form 4
|
∞
| 2.3K |
—
|
—
| 2.3K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||